Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Log ind
Få fuld adgang
ROS Therapeutics Holding ApS
APS
Active
CVR 39507056
Ole Maaløes Vej 3, 2200
København N
Ikke-finansielle holdingselskaber
·
NACE 6421
Stiftet 2018 · 8 år gammel
— ansatte
Overvåg
Del
Danmark
/
Virksomheder
/
Activities of holding companies
/
ROS Therapeutics Holding ApS
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Personer & ejerskab
Ledelse
Nuværende ledelse
Name
Role
Member since
Current (1)
HD
Hanne Damgaard Jensen
Management
Management
2018
Bestyrelse
Bestyrelsestilsyn
Name
Role
Member since
Tidligere (4)
MH
Mads Hartvig Clausen
Board of Directors
Board of Directors
2018 – 2019
CP
Christian Philip Hansen
Board of Directors
Board of Directors
2018 – 2018
JB
Jon Bondebjerg
Board of Directors
Board of Directors
2018 – 2019
HD
Hanne Damgaard Jensen
Chairman
Chairman
2018 – 2019
Aktionærer
Pr. seneste årsrapport
HDJ & LEJ Invest ApS — 66.67–89.99%
SPORCON LIFESCIENCE ADVISORS ApS — 10–14.99%
Pebean Pharma ApS — 5–9.99%
ROS Therapeutics Holding ApS — 10–14.99%
Abihansen Holding IVS — 25–33.32%
2200 HOLDING ApS — 25–33.32%
Liltorp-Bondebjerg Invest ApS — 25–33.32%
100%
Shareholder
Type
Ownership
Votes
Since
HDJ & LEJ Invest ApS
Company
66.67–89.99%
66.67–89.99%
2018
SPORCON LIFESCIENCE ADVISORS ApS
Company
10–14.99%
10–14.99%
2020
Pebean Pharma ApS
Company
5–9.99%
5–9.99%
2023
ROS Therapeutics Holding ApS
Company
10–14.99%
10–14.99%
2021
Abihansen Holding IVS
Company
25–33.32%
25–33.32%
2018
2200 HOLDING ApS
Company
25–33.32%
25–33.32%
2018
Liltorp-Bondebjerg Invest ApS
Company
25–33.32%
25–33.32%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Mere om ROS Therapeutics Holding ApS
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Regnskaber & nøgletal →
Omsætning, EBITDA, balance og 5-års udvikling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk